| Product Code: ETC10939630 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Vaccine Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Vaccine Market - Industry Life Cycle |
3.4 Taiwan Vaccine Market - Porter's Five Forces |
3.5 Taiwan Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Taiwan Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Taiwan Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Taiwan Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Taiwan Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Taiwan Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing diseases |
4.2.2 Government initiatives and policies promoting vaccination programs |
4.2.3 Rising incidences of infectious diseases driving the demand for vaccines |
4.3 Market Restraints |
4.3.1 Regulatory challenges and stringent approval processes for new vaccines |
4.3.2 Limited access to healthcare services in certain regions of Taiwan |
4.3.3 Vaccine hesitancy and misinformation impacting vaccination rates |
5 Taiwan Vaccine Market Trends |
6 Taiwan Vaccine Market, By Types |
6.1 Taiwan Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Taiwan Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F |
6.1.4 Taiwan Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F |
6.1.5 Taiwan Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.2 Taiwan Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.3 Taiwan Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F |
6.2.4 Taiwan Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 Taiwan Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F |
6.3.3 Taiwan Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.4 Taiwan Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F |
6.4 Taiwan Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4.3 Taiwan Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Taiwan Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Taiwan Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Taiwan Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F |
6.5.3 Taiwan Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F |
6.5.4 Taiwan Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F |
7 Taiwan Vaccine Market Import-Export Trade Statistics |
7.1 Taiwan Vaccine Market Export to Major Countries |
7.2 Taiwan Vaccine Market Imports from Major Countries |
8 Taiwan Vaccine Market Key Performance Indicators |
8.1 Vaccination coverage rate among different age groups in Taiwan |
8.2 Number of vaccines included in the national immunization schedule |
8.3 Research and development investment in new vaccine technologies |
9 Taiwan Vaccine Market - Opportunity Assessment |
9.1 Taiwan Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Taiwan Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Taiwan Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Taiwan Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Taiwan Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Taiwan Vaccine Market - Competitive Landscape |
10.1 Taiwan Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here